FI970247A - Farmaseuttisia koostumuksia, jotka sisältävät kimeerisen TNF:ää sitovan proteiinin - Google Patents

Farmaseuttisia koostumuksia, jotka sisältävät kimeerisen TNF:ää sitovan proteiinin Download PDF

Info

Publication number
FI970247A
FI970247A FI970247A FI970247A FI970247A FI 970247 A FI970247 A FI 970247A FI 970247 A FI970247 A FI 970247A FI 970247 A FI970247 A FI 970247A FI 970247 A FI970247 A FI 970247A
Authority
FI
Finland
Prior art keywords
pharmaceutical compositions
binding protein
compositions containing
tnf binding
chimeric tnf
Prior art date
Application number
FI970247A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI970247A0 (fi
Inventor
Robert Fredrich Geoffrey Booth
Werner Lesslauer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI970247A publication Critical patent/FI970247A/fi
Publication of FI970247A0 publication Critical patent/FI970247A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI970247A 1994-07-22 1997-01-21 Farmaseuttisia koostumuksia, jotka sisältävät kimeerisen TNF:ää sitovan proteiinin FI970247A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94111455 1994-07-22
PCT/EP1995/002788 WO1996003141A1 (en) 1994-07-22 1995-07-15 Pharmaceutical compositions comprising a chimaeric tnf binding protein

Publications (2)

Publication Number Publication Date
FI970247A true FI970247A (fi) 1997-01-21
FI970247A0 FI970247A0 (fi) 1997-01-21

Family

ID=8216138

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970247A FI970247A0 (fi) 1994-07-22 1997-01-21 Farmaseuttisia koostumuksia, jotka sisältävät kimeerisen TNF:ää sitovan proteiinin

Country Status (11)

Country Link
EP (1) EP0772449A1 (de)
JP (1) JPH09508140A (de)
AU (1) AU3111995A (de)
BR (1) BR9508419A (de)
CA (1) CA2195665A1 (de)
CZ (1) CZ283219B6 (de)
FI (1) FI970247A0 (de)
HU (1) HUT76666A (de)
NO (1) NO970264L (de)
PL (1) PL318501A1 (de)
WO (1) WO1996003141A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001968A (en) 1994-08-17 1999-12-14 The Rockefeller University OB polypeptides, modified forms and compositions
US6429290B1 (en) 1994-08-17 2002-08-06 The Rockefeller University OB polypeptides, modified forms and derivatives
US6350730B1 (en) 1994-08-17 2002-02-26 The Rockefeller University OB polypeptides and modified forms as modulators of body weight
US6471956B1 (en) 1994-08-17 2002-10-29 The Rockefeller University Ob polypeptides, modified forms and compositions thereto
US20030040467A1 (en) 1998-06-15 2003-02-27 Mary Ann Pelleymounter Ig/ob fusions and uses thereof.
US6936439B2 (en) 1995-11-22 2005-08-30 Amgen Inc. OB fusion protein compositions and methods
JP2000510113A (ja) * 1996-05-08 2000-08-08 エフ・ホフマン―ラ ロシュ アーゲー ＴＮＦＲ―Ｉｇによる喘息の治療
TW555765B (en) * 1996-07-09 2003-10-01 Amgen Inc Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
US7070771B1 (en) 1996-12-09 2006-07-04 Regents Of The University Of California Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells
CA2272822A1 (en) * 1996-12-12 1998-06-18 Genentech, Inc. Hvem polypeptides and uses thereof
DE69911641T2 (de) 1998-11-27 2004-08-05 Synaptics (Uk) Ltd., Harston Positionssensor
EE200300408A (et) 2001-02-23 2003-12-15 Immunex Corporation Aktiivsete valkude saagise suurendamine
WO2003011323A1 (en) * 2001-07-30 2003-02-13 Genset S.A. Agonists and antagonists of contabix for use in the treatment of metabolic disorders
US7786282B2 (en) 2001-12-06 2010-08-31 The Regents Of The University Of California Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain
AU2003209755B2 (en) 2002-02-06 2007-11-22 Ares Trading S.A. Tumor necrosis factor combined with interferon in demyelinating diseases
NZ554520A (en) 2004-10-22 2010-03-26 Amgen Inc Methods for refolding of recombinant antibodies
WO2016029043A1 (en) 2014-08-21 2016-02-25 The General Hospital Corporation Tumor necrosis factor superfamily and tnf-like ligand muteins and methods of preparing and using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL98078A0 (en) * 1991-05-07 1992-06-21 Yeda Res & Dev Pharmaceutical compositions comprising an anticytokyne
EP1132471A3 (de) * 1989-09-12 2001-11-28 F. Hoffmann-La Roche Ag TNF-bindende Proteine
GB9015908D0 (en) * 1990-07-19 1990-09-05 Celltech Ltd Multivalent immunoglobulin
WO1994006476A1 (en) * 1992-09-15 1994-03-31 Immunex Corporation Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists
CA2147180A1 (en) * 1992-10-15 1994-04-28 Gokhan S. Hotamisligil Treatment of insulin resistance in obesity linked type ii diabetes using antagonists to tnf-.alpha. function

Also Published As

Publication number Publication date
AU3111995A (en) 1996-02-22
WO1996003141A1 (en) 1996-02-08
EP0772449A1 (de) 1997-05-14
FI970247A0 (fi) 1997-01-21
NO970264D0 (no) 1997-01-21
HUT76666A (en) 1997-10-28
NO970264L (no) 1997-03-24
BR9508419A (pt) 1997-11-18
CA2195665A1 (en) 1996-02-08
CZ19397A3 (en) 1997-06-11
PL318501A1 (en) 1997-06-23
JPH09508140A (ja) 1997-08-19
CZ283219B6 (cs) 1998-02-18

Similar Documents

Publication Publication Date Title
HUP9701554D0 (en) Pharmaceutical composition containing plazma proteins
FI970247A0 (fi) Farmaseuttisia koostumuksia, jotka sisältävät kimeerisen TNF:ää sitovan proteiinin
ZA947122B (en) Drug binding protein.
IS4565A (is) 2-methýl-thíenó-bensódíasepín, samsetning til inntöku
FI965202A0 (fi) Farmaseuttiset takriinikoostumukset
CY2005007I1 (el) Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη
ID22891A (id) Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
IS4974A (is) Lyfjasamsetning á þrýstingsúðaformi
HU9503199D0 (en) Pharmaceutical basic compositions
DE69508180D1 (de) Heissschmelzende Tintenstrahlzusammensetzung
GB9722600D0 (en) Pharmaceutical compositon
EP0796321A4 (de) E2 bindungsprotein
EE9800400A (et) Diklofenaaki sisaldavad farmatseutilised kompositsioonid
BR9507768A (pt) Composição farmacêutica
DE69705017D1 (de) Medikamente bindendes Protein
ZA984826B (en) Novel anti-diabetic composition.
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
FI962738A (fi) Farmaseuttiset koostumukset
LTIP2039A (en) Binding composition, containing anhydrite
ITMI950120A0 (it) Composizione farmaceutica contenente n-acetil-cisteina
IL110319A0 (en) Pharmaceutical compositions containing protein
SE9402924D0 (sv) Novel pharmaceutical composition
GB9409736D0 (en) Biocidal protein compositions
HU9802107D0 (en) Pharmaceutical composition containing plazma proteins
TR199500776A2 (tr) Farmasötik bilesimler.